Jagsonpal Pharmaceuticals Limited — Board Meeting, 06-05-2025: Outcome of Board Meeting

Jagsonpal Pharmaceuticals has announced a board meeting on which it approved the financial results for the quarter and half-year. Profit before tax surged to Rs. 698.59 million, more than doubling from last year’s Rs. 298.69 million. A final dividend of Rs. 2.5 per share is proposed, subject to shareholder approval. The company strengthened its dermatology and childcare segment by acquiring Yash Pharma’s India and Bhutan business for Rs. 940.12 million. M/s. S S Kothari Mehta & Co. was appointed as the internal auditor for FY 2025-26.